Development of a water-soluble polarity/reactive nitrogen species dual-responsive fluorescence probe with enhanced specificity/sensitivity for early-stage non-alcoholic fatty liver disease diagnosis

IF 5.3 2区 化学 Q1 CHEMISTRY, ANALYTICAL
Haiping Wang, Li Luo, Feifei Han, Sibei Peng, Li Wang, Xiji Shu, Binlian Sun, Yuchen Liu, Song Zhang, Yao Yu
{"title":"Development of a water-soluble polarity/reactive nitrogen species dual-responsive fluorescence probe with enhanced specificity/sensitivity for early-stage non-alcoholic fatty liver disease diagnosis","authors":"Haiping Wang,&nbsp;Li Luo,&nbsp;Feifei Han,&nbsp;Sibei Peng,&nbsp;Li Wang,&nbsp;Xiji Shu,&nbsp;Binlian Sun,&nbsp;Yuchen Liu,&nbsp;Song Zhang,&nbsp;Yao Yu","doi":"10.1007/s00604-025-07533-y","DOIUrl":null,"url":null,"abstract":"<div><p>Non-alcoholic fatty liver disease (NAFLD) is a global health concern, but early diagnosis remains challenging due to the limitations of current methods, which are often invasive or lack sensitivity. To address this, we developed UIO-YB, a dual-responsive fluorescence probe combining water-soluble UIO carriers with a polarity-sensitive dye (YB) for precise NAFLD detection. UIO-YB exhibits dual fluorescence emission (red for YB, blue for UIO), enabling simultaneous detection of lipid accumulation (via YB’s polarity response) and oxidative stress markers (via UIO’s RNS reactivity). In vitro, UIO-YB detected lipid droplets in HepG2 cells within 2 h, surpassing Oil Red O in speed and simplicity. In vivo, it accurately visualized Hepatic steatosis in mice after 6 weeks of a high-fat diet, demonstrating high specificity and sensitivity. Unlike conventional dyes, UIO-YB operates without organic solvents, simplifying protocols while reducing background noise. UIO-YB’s water solubility and dual-response design overcome key limitations of existing probes, offering a rapid, scalable tool for early NAFLD detection. Its performance in cellular and preclinical models highlights its potential to advance NAFLD research and clinical diagnostics. This innovation paves the way for non-invasive, high-sensitivity imaging to improve disease monitoring and intervention.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":705,"journal":{"name":"Microchimica Acta","volume":"192 10","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microchimica Acta","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s00604-025-07533-y","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a global health concern, but early diagnosis remains challenging due to the limitations of current methods, which are often invasive or lack sensitivity. To address this, we developed UIO-YB, a dual-responsive fluorescence probe combining water-soluble UIO carriers with a polarity-sensitive dye (YB) for precise NAFLD detection. UIO-YB exhibits dual fluorescence emission (red for YB, blue for UIO), enabling simultaneous detection of lipid accumulation (via YB’s polarity response) and oxidative stress markers (via UIO’s RNS reactivity). In vitro, UIO-YB detected lipid droplets in HepG2 cells within 2 h, surpassing Oil Red O in speed and simplicity. In vivo, it accurately visualized Hepatic steatosis in mice after 6 weeks of a high-fat diet, demonstrating high specificity and sensitivity. Unlike conventional dyes, UIO-YB operates without organic solvents, simplifying protocols while reducing background noise. UIO-YB’s water solubility and dual-response design overcome key limitations of existing probes, offering a rapid, scalable tool for early NAFLD detection. Its performance in cellular and preclinical models highlights its potential to advance NAFLD research and clinical diagnostics. This innovation paves the way for non-invasive, high-sensitivity imaging to improve disease monitoring and intervention.

Graphical Abstract

一种水溶性极性/活性氮双响应荧光探针在早期非酒精性脂肪肝诊断中的特异性/敏感性增强
非酒精性脂肪性肝病(NAFLD)是一个全球性的健康问题,但由于现有方法的局限性,早期诊断仍然具有挑战性,这些方法通常是侵入性的或缺乏敏感性。为了解决这个问题,我们开发了UIO-YB,一种双响应荧光探针,将水溶性UIO载体与极性敏感染料(YB)结合在一起,用于精确检测NAFLD。UIO-YB显示双荧光发射(红色为YB,蓝色为UIO),可以同时检测脂质积累(通过YB的极性响应)和氧化应激标志物(通过UIO的RNS反应性)。在体外,UIO-YB在2 h内检测到HepG2细胞中的脂滴,在速度和简单性上超过了Oil Red O。在体内实验中,它能准确地显示高脂肪饮食6周后小鼠的肝脏脂肪变性,具有很高的特异性和敏感性。与传统染料不同,UIO-YB在没有有机溶剂的情况下运行,简化了程序,同时降低了背景噪音。UIO-YB的水溶性和双响应设计克服了现有探针的主要限制,为早期NAFLD检测提供了快速,可扩展的工具。它在细胞和临床前模型中的表现突出了其推进NAFLD研究和临床诊断的潜力。这一创新为非侵入性、高灵敏度成像铺平了道路,以改善疾病监测和干预。图形抽象
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microchimica Acta
Microchimica Acta 化学-分析化学
CiteScore
9.80
自引率
5.30%
发文量
410
审稿时长
2.7 months
期刊介绍: As a peer-reviewed journal for analytical sciences and technologies on the micro- and nanoscale, Microchimica Acta has established itself as a premier forum for truly novel approaches in chemical and biochemical analysis. Coverage includes methods and devices that provide expedient solutions to the most contemporary demands in this area. Examples are point-of-care technologies, wearable (bio)sensors, in-vivo-monitoring, micro/nanomotors and materials based on synthetic biology as well as biomedical imaging and targeting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信